Cite

HARVARD Citation

    Chen, S. et al. (2023). Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Reduces Infarct Size Independently of Sodium Glucose Cotransporter-2. Circulation. 147 (3), pp. 276-279. [Online]. 
  
Back to record